Skip to content
10-Q

Quarterly Report

T2 Biosystems, Inc.

0000950170-24-126996

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 11, 2024 21.04M sh
Shares Diluted Q3 2024 · Sep 30, 2024 17.89M sh
Shares Diluted Q3 2024 · Sep 30, 2024 12.38M sh
Shares Diluted Q3 2024 · Sep 30, 2023 4.48M sh
Shares Diluted Q3 2024 · Sep 30, 2023 1.82M sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$27.18M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$38.72M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $2.08M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $15.69M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $24.32M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$11.71M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$5.9M
Stockholders Equity Q3 2024 · Mar 31, 2024 −$37.77M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$28.04M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$19.24M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$36.42M
Stockholders Equity Q3 2024 · Mar 31, 2023 −$49.89M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$39.66M
Current Liabilities Q3 2024 · Sep 30, 2024 $24.44M
Current Liabilities Q3 2024 · Dec 31, 2023 $56.15M
Total Liabilities Q3 2024 · Sep 30, 2024 $29.79M
Total Liabilities Q3 2024 · Dec 31, 2023 $62.83M
Current Assets Q3 2024 · Sep 30, 2024 $9.79M
Current Assets Q3 2024 · Dec 31, 2023 $25.19M
Total Assets Q3 2024 · Sep 30, 2024 $18.08M
Total Assets Q3 2024 · Dec 31, 2023 $34.8M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.57
Eps Diluted Q3 2024 · Sep 30, 2024 −$2.63
Eps Diluted Q3 2024 · Sep 30, 2023 −$3.45
Eps Diluted Q3 2024 · Sep 30, 2023 −$21.79
Eps Basic Q3 2024 · Sep 30, 2024 −$0.57
Eps Basic Q3 2024 · Sep 30, 2024 −$2.63
Eps Basic Q3 2024 · Sep 30, 2023 −$3.45
Eps Basic Q3 2024 · Sep 30, 2023 −$21.79
Sga Expense Q3 2024 · Sep 30, 2024 $5.38M
Sga Expense Q3 2024 · Sep 30, 2024 $17.59M
Sga Expense Q3 2024 · Sep 30, 2023 $5.98M
Sga Expense Q3 2024 · Sep 30, 2023 $19.58M
Rd Expense Q3 2024 · Sep 30, 2024 $2.67M
Rd Expense Q3 2024 · Sep 30, 2024 $9.75M
Rd Expense Q3 2024 · Sep 30, 2023 $2.66M
Rd Expense Q3 2024 · Sep 30, 2023 $10.98M
Net Income Q3 2024 · Sep 30, 2024 −$10.12M
Net Income Q3 2024 · Sep 30, 2024 −$32.61M
Net Income Q3 2024 · Jun 30, 2024 −$8.96M
Net Income Q3 2024 · Mar 31, 2024 −$13.53M
Net Income Q3 2024 · Sep 30, 2023 −$15.43M
Net Income Q3 2024 · Sep 30, 2023 −$39.74M
Net Income Q3 2024 · Jun 30, 2023 −$6.35M
Net Income Q3 2024 · Mar 31, 2023 −$17.97M
Operating Income Q3 2024 · Sep 30, 2024 −$10.16M
Operating Income Q3 2024 · Sep 30, 2024 −$32.34M
Operating Income Q3 2024 · Sep 30, 2023 −$13.61M
Operating Income Q3 2024 · Sep 30, 2023 −$40.35M
Revenue Q3 2024 · Sep 30, 2024 $1.99M
Revenue Q3 2024 · Sep 30, 2024 $6M
Revenue Q3 2024 · Sep 30, 2023 $1.47M
Revenue Q3 2024 · Sep 30, 2023 $5.51M
Capex Q3 2024 · Sep 30, 2023 $166K